These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37428806)

  • 41. Preinduction of heat shock protein 70 protects mice against post-infection irritable bowel syndrome via NF-κB and NOS/NO signaling pathways.
    Zhou X; Dong L; Yang B; He Z; Chen Y; Deng T; Huang B; Lan C
    Amino Acids; 2015 Dec; 47(12):2635-45. PubMed ID: 26215736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA-495 reduces visceral sensitivity in mice with diarrhea-predominant irritable bowel syndrome through suppression of the PI3K/AKT signaling pathway via PKIB.
    Fei L; Wang Y
    IUBMB Life; 2020 Jul; 72(7):1468-1480. PubMed ID: 32187820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electroacupuncture Improving Intestinal Barrier Function in Rats with Irritable Bowel Syndrome Through Regulating Aquaporins.
    Kang X; Zhang H; Li X; Zhang K; Huang Z; Li Y; Ren X; Chai Y
    Dig Dis Sci; 2024 Apr; 69(4):1143-1155. PubMed ID: 38421507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Berberine Attenuates Neonatal Sepsis in Mice By Inhibiting FOXA1 and NF-κB Signal Transduction Via the Induction of MiR-132-3p.
    Li B; Niu S; Geng H; Yang C; Zhao C
    Inflammation; 2021 Dec; 44(6):2395-2406. PubMed ID: 34523052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
    Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-345-3p attenuates apoptosis and inflammation caused by oxidized low-density lipoprotein by targeting TRAF6 via TAK1/p38/NF-kB signaling in endothelial cells.
    Wei Q; Tu Y; Zuo L; Zhao J; Chang Z; Zou Y; Qiu J
    Life Sci; 2020 Jan; 241():117142. PubMed ID: 31825793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of serum microRNA expression by acupuncture in patients with diarrhea-predominant irritable bowel syndrome.
    Guo J; Lu G; Chen L; Geng H; Wu X; Chen H; Li Y; Yuan M; Sun J; Pei L
    Acupunct Med; 2022 Feb; 40(1):34-42. PubMed ID: 34231397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR-142a-3p alleviates Escherichia coli derived lipopolysaccharide-induced acute lung injury by targeting TAB2.
    Yang Y; Yang C; Guo YF; Liu P; Guo S; Yang J; Zahoor A; Shaukat A; Deng G
    Microb Pathog; 2019 Nov; 136():103721. PubMed ID: 31494298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis.
    Lu WX
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7356-7368. PubMed ID: 31539122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
    Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
    Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus.
    Xia P; Chen J; Liu Y; Cui X; Wang C; Zong S; Wang L; Lu Z
    J Neuroinflammation; 2022 Jul; 19(1):180. PubMed ID: 35821145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
    He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
    Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-29a-3p Enhances the Viability of Rat Neuronal Cells that Injured by Oxygen-Glucose Deprivation/Reoxygenation Treatment Through Targeting TNFRSF1A and Regulating NF-κB Signaling Pathway.
    Gao XZ; Zhang ZX; Han GL
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105210. PubMed ID: 33066952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of microRNA-142-3p inhibits the aggressive phenotypes of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting nuclear factor-κB signaling.
    Qiang J; Lv T; Wu Z; Yang X
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-17-3p suppresses NF-κB-mediated endothelial inflammation by targeting NIK and IKKβ binding protein.
    Cai Y; Zhang Y; Chen H; Sun XH; Zhang P; Zhang L; Liao MY; Zhang F; Xia ZY; Man RY; Feinberg MW; Leung SW
    Acta Pharmacol Sin; 2021 Dec; 42(12):2046-2057. PubMed ID: 33623121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CircTRHDE knockdown protects WI-38 cells against LPS-induced inflammatory injury.
    Sun L; Liu J; Sun X; Zhang Y; Cui X
    Autoimmunity; 2022 Jun; 55(4):233-242. PubMed ID: 35481453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway.
    Han S; Lin F; Ruan Y; Zhao S; Yuan R; Ning J; Jiang K; Xie J; Li H; Li C; Rao T; Yu W; Xia Y; Zhou X; Cheng F
    Int Immunopharmacol; 2021 Oct; 99():108022. PubMed ID: 34339961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-29b-3p protects cardiomyocytes against endotoxin-induced apoptosis and inflammatory response through targeting FOXO3A.
    Li Z; Yi N; Chen R; Meng Y; Wang Y; Liu H; Cao W; Hu Y; Gu Y; Tong C; Lu M; Li L; Peng L
    Cell Signal; 2020 Oct; 74():109716. PubMed ID: 32707074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Effect and Mechanism of Sancao Lichang Decoction on Diarrhea- Predominant Irritable Bowel Syndrome by Regulating Tlr4/Myd88/Nf-Κb Pathway.
    Zhang P; Ma Y; Wang Z; Tang D
    Comb Chem High Throughput Screen; 2023; 26(13):2372-2379. PubMed ID: 36856180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.